Lanean...
Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model
TH-302, a hypoxia-activated anticancer prodrug was evaluated for anti-tumor activity and changes in dynamic contrast enhanced (DCE)- and diffusion weighted (DW)-magnetic resonance imaging (MRI) in a mouse model of pancreatic cancer. TH-302 monotherapy resulted in a significant delay in tumor growth...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3402593/ https://ncbi.nlm.nih.gov/pubmed/22554971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mri.2012.02.015 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|